Maintenance / Service
PRODUCTS
-
Enable co-location of cell culture media and buffer manufacturing and bioproduction with Krakatoa K500, the first bioreactor-scale pod-based manufacturing system. Produce up to 500 liters of sterile solutions on-demand in less than 3 hours.
-
Deliver cost-effective, reliable public infrastructure—from permitting and construction to operation, maintenance and replacement. From the office to the field, Trimble Cityworks helps you improve service to your community while increasing safety, efficiency and performance.
-
Enabling organizations of all sizes to transform their business through better use of technology.
-
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.
-
ReadyToProcess™ columns are validated prepacked columns designed for scale-up and GMP manufacturing. Using prepacked columns reduces costs by eliminating the need for column packing, preparation and validation procedures.
WHITE PAPERS AND CASE STUDIES
-
Catalent's Journey Of Continuous Improvement For CSV Excellence
Learn how organizations must continuously reassess validation processes and digital tools to ensure compliance, enhance efficiency, and support global scalability amidst evolving regulatory expectations.
-
Unlock The Power Of Clinical Data Science
Discover a unified, AI‑driven approach that helps clinical teams manage growing data complexity, accelerate insight generation, and improve trial oversight to enable faster decisions.
-
Mobile App And Wearable Integration Collects Longitudinal Data
Get an overview of SISCAPA's utilization of eTechnologies, specifically ePRO, and how their partnership with CDS accurately demonstrates the improvement of data collection and analysis in the biotechnology industry.
-
Overcoming Analytical Bottlenecks In Oligonucleotide Drug Development With Automation
Growing oligonucleotide complexity is straining traditional analytical workflows. See how automated LC‑UV‑MS processing offers a scalable way to boost throughput and reduce manual effort.
-
The Most Significant Quality Measurement For Manufacturers
Learn how a life sciences manufacturer generated a contextualized data set that eliminated the manual effort required to curate production data and improved their process in real time.
-
How A CDMO Gained 40%+ Efficiency By Generating Automated APQRs
Discover how a CDMO's mounting challenges with manual product quality review (PQR) processes were resolved through the implementation of a next-generation cloud-based solution.
-
Lakewood Transforms Water Management With Digital Twin Technology
The City of Lakewood, California, embarked on a groundbreaking project to simplify and enhance its water distribution system using Qatium’s innovative digital twin technology.
-
Kimberly-Clark Streamlines Supplier Management
Find out how Kimberly-Clark implemented software to centralize and secure supplier contract management to enhance efficiency and achieve a 3,200% ROI through streamlined processes.
-
The Untapped Power Of Real-World Data And AI In Pharma Commercialization
Harnessing RWD in commercialization bridges the gap between approval and patient access, equipping companies with actionable intelligence to deliver life-changing therapies to more patients.
-
Operational Success By Strategic Investment
Explore how infrastructure, equipment strategy, and advanced technologies shape a more reliable path for scaling sterile injectable programs.
-
Digital Biomanufacturing, Now: From Digital Dreamer To Digital Doer
Discover how digital biomanufacturing is revolutionizing drug production by exploring strategies for integrating digital technologies to enhance efficiency and innovation in bioprocessing workflows.
-
Beyond The Benchmark: Innovative Trial Designs Transform Research
Adaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.
NEWS
-
memsstar's ORBIS Alpha Etch System Installed In TUM Quantum Networks Lab3/25/2026
memsstar Ltd., a leading provider of etch and deposition equipment to researchers and manufacturers of semiconductors and micro-electromechanical systems (MEMS), today announced the installation and characterisation of its ORBIS™ Alpha Xeric Oxide Etch system at the Garching, Germany, campus of the Technical University of Munich (TUM).
-
Citybox Adopts Mews To Streamline Operations And Scale Innovation Across The Nordics2/4/2026
Fast-growing Norwegian hotel group, Citybox, has selected Mews, the leading operating system for hospitality and shared spaces, as its property management system to power its multi-country portfolio and accelerate the brand’s mission to deliver the most seamless customer experience in the industry.
-
Angel Yeast Showcased Yeast And Biotechnology Products & Services In Gulfood 20261/26/2026
The 31st Gulfood 2026 kicked off at the Dubai World Trade Centre on January 26, running until January 30. Angel Yeast participated in the exhibition with the core concept of "Technology Empowers Nutrition, Yeast Leads the Future," fully demonstrating its innovative capabilities and full-industry-chain service strength in the field of yeast and biotechnology.
-
Sutro Biopharma And Boehringer Ingelheim BioXcellence™ Collaboration: Established First-In-Class Cell-Free Capabilities At Commercial Scale1/7/2025
Boehringer Ingelheim BioXcellence™ and Sutro Biopharma Inc. today announced that they successfully applied Sutro’s proprietary cell-free expression technology on a commercial scale to manufacture luveltamab tazevibulin (luvelta), Sutro’s Tubulin FRα-targeting antibody-drug conjugate (ADC) designed to treat a broad range of patients with ovarian cancer and other FRα expressing cancers.
-
Zymeworks Receives U.S. FDA Fast Track Designation For ZW191, An Frα-Targeting Antibody-Drug Conjugate3/30/2026
Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ZW191, an antibody-drug conjugate (ADC) targeting folate receptor-α (FRα), for the treatment of patients with advanced or metastatic platinum-resistant ovarian cancer (PROC).